KMS Medisurgi Share Price

CMP as on20-Oct-21 12:50

₹ 34.10
0 0%

Open

₹ 34.20

Turnover (lac)

Prev. Close

₹ 34.10

Day's Vol (shares)

₹ 16,000

Day's Range

₹ 34.10
₹ 34.20

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 02-Sep-2021 - -
KMS Medisurgi Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/09/2021 inter alia to consider and approve 1. To consider a Final Dividend of Re.0.05 (0.5%) per equity share of Face Value of Rs 10/- each for the Financial Year 2020-21. 2. To Consider and fix day date time and venue and calendar or events in connection with for 23rd Annual General Meeting of the Company 3. To adopt Directors Report for F.Y. 2020-21 and notice for 23rd Annual General Meeting and recommend to the members Balance Sheet Profit & Loss A/c Cash Flow Auditors Report and Notes thereon. 4. To fix the dates for the closing or Register of Members and Transfer Books in connection with 23rd Annual General Meeting of the Company. 5. To adopt Secretarial Audit Report for F.Y 2020-21 and take note on observation/Comments/qualification made by Secretarial auditors if any. 6. To consider other business if any. Declaration of Final Dividend of Re.0.05 (0.5%) per equity share of Face Value of Rs 10/- each, for the Financial Year ended 2020-21. Outcome of Board meeting held on 6th September 2021. (As Per BSE Announcement Dated on 06.09.2021)
Board Meeting - 22-Jun-2021 - -
KMS Medisurgi Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/06/2021 ,inter alia, to consider and approve 1. To adopt Audited Financial Results for the quarter and financial year ended 31st March 2021; 2. To adopt and approve the Balance Sheet for the year ended 31st March, 2021 together with Profit and Loss Account and Cashflow statement as on that date and Report of the Auditors thereon. 3. To consider other business, if any. In compliance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit the following: 1. Standalone Audited Financial Results for the quarter and year ended 31st March 2021 including Statement of Assets & Liabilities and Cashflow statement as on that date; 2. Auditors Report for the quarter and year ended 31st March 2021; and 3. Declaration of Un-modified opinion on the Audited Financial Results for the year ended 31st March, 2021.¬ Kindly take the same on your record and oblige. In terms of Regulation 30 read with Part A of Schedule III and other applicable Regulation of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform that the meeting of the Board of Directors of our Company was held on Tuesday, June 29, 2021 at 4.30 pm, the time scheduled for meeting, and concluded at 5.30 pm, (AS Per BSE Announcement Dated on 29.06.2021)
Board Meeting - 03-Mar-2021 - -
Appointment of Ms. Mariam Bahnan, an Associate member of the Institute of Company Secretaries of India (ICSI) having Membership Number A60480, as a Company Secretary and Compliance Officer of the Company with effect from 3rd March 2021.
Board Meeting - 03-Nov-2020 - -
KMS Medisurgi Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2020 ,inter alia, to consider and approve This is to inform you that Pursuant to Regulation 29 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, a meeting of the Board of Directors of KMS Medisurgi limited (the Company) will be held on Friday, 13th day of November, 2020 at 03:00 P.M. at the Registered Office of the Company at 297/301, Ground Floor, May Building, Princess Street, Marine Lines (East), Mumbai 400 002 inter-alia, to consider, approve and take on record the Unaudited Financial Results of the Company for the half year ended 30th September, 2020 and any other Business matter, with the permission of the chair. Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we forward Standalone unaudited financial results for the half year ended 30th September, 2020 approved by the Board of Directors of the company at their meeting held on today, the 13th, November, 2020, as recommended by Audit Committee along with the Limited Review report. (As Per BSE Announcement dated on 13.11.2020)
Open ZERO Brokerage Demat Account